Inhalation Anesthesia Market to cross $1.6 billion by 2024: Global Market Insights, Inc.

Inhalation Anesthesia Market By Product (Sevoflurane, Desflurane, Isoflurane), By Application (Induction, Maintenance), Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, Australia, India, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Technology Development, Competitive Landscape & Global Forecast (2017 – 2024)

Selbyville, Delaware, UNITED STATES


Ocean View, Delaware, Sept. 18, 2017 (GLOBE NEWSWIRE) --

Inhalation Anesthesia Market is poised to surpass USD 1.6 billion by 2024; according to a new research report by Global Market Insights, Inc. Rising number of geriatric population coupled with increasing number of chronic diseases such as cancer, cardiovascular, neurological, and respiratory disorders and introduction of advanced anesthesia will offer lucrative growth opportunities for the inhalation anesthesia market growth.

Increasing number of emergency surgeries driving the count of hospital admissions coupled with favorable private and public insurance will drive the inhalation anesthesia market. Growing investment in healthcare infrastructure development in emerging economies and increasing adoption of universal health coverage resulting in demand among public as well as private healthcare setups will propel the business growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/704

Increasing number of surgeries performed in ambulatory surgical centers will stimulate business growth over the forecast years. Growing adoption of inhalation anesthesia for globally rising prevalence of cataract surgeries, enhanced access to healthcare treatments, and rise in disposable income will fuel the industry growth.

Adverse side effects during recovery, procedure or surgery, or wearing off anesthesia coupled with effect like intraoperative discomfort, hypotension, post-lumbar-puncture headache, and potential for neurologic and cardiac toxicity from anesthetics may hamper the inhalation anesthesia market growth.

Browse key industry insights spread across 130 pages with 168 market data tables & 9 figures & charts from the report, “Inhalation anesthesia Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/inhalation-anesthesia-market

Sevoflurane segment accounted for the highest revenue share in 2016 and will grow at a significant rate over the forecast period owing to growing use in both maintenance and induction. Isoflurane segment will grow at a significant rate pertaining to associated factors like systemic vessels expand and potentiates activities of muscle relaxants, preferred for neurosurgery, and sustained cardiac outputs will boost the business growth.

Maintenance accounted for highest revenue share of the application segment in 2016 and will grow at a significant rate over the forecast period owing to factors like safety of airway as nearly all patients that are anesthetized by means of these products are intubated. Increasing use in patients with low oxygen carrying capacities such as the patients with respirational dysfunction or anemia will fuel the segment growth in the coming years.

U.S. market was valued over USD 488 million in 2016 and will grow significantly over the coming years. Rising number of plastic surgeries and substantially increasing adoption rate of the process will drive the business growth in U.S. Furthermore, presence of associations that aids in maintaining the standards of anesthesiology will fuel the industry growth in the country.

Germany accounted for highest revenue share in the region, owing to increasing chronic conditions associated with elderly population coupled with adoption rate of inhalation anesthesia. Growing prevalence of cancers and cardiovascular disorders accounting for approximately 66% of overall deaths in Germany will drive the industry growth over the forecast years.

China will grow at a significant rate owing to its growing research studies in the business and high prevalence of lung cancer occurred due to pollution. Increasing use of sevoflurane and desflurane in general anesthesia pertaining to superiority of awakening afterwards surgical procedure as compared to traditional inhaled anesthetics will drive the industry growth in the country. Presence of organizations and associations offering platform for research and findings for anesthesia and mounting occurrence of chronic conditions will fuel the business growth in India.

Brazil is projected to grow at a substantial rate over the forecast period. Increasing prevalence of chronic conditions coupled with high adoption of inhalation anesthesia technique as compared to intravenous anesthesia (AVT) will stimulate business expansion in the country.

Some of the companies operating in market are Abbott, Baxter International, Piramal, Lunan Pharmaceutical, Hikma Pharmaceuticals and Halocarbon Products. Introduction of novel product and growing focus on geographical expansion will propel the industry growth. Key industry players will endeavor to reinforce their position in this competitive market by implementing these strategies.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/704

Browse Related Reports:

  • Respiratory Disease Testing Market Size 2017 – 2024

Respiratory Disease Testing Market share is projected to experience significant growth from 2017 to 2024. Respiratory disease testing market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years.

https://www.gminsights.com/industry-analysis/respiratory-disease-testing-market

  • Therapeutic Respiratory Devices Market Size 2017 – 2024

Therapeutic Respiratory Devices Market share was valued at over USD 8.5 billion in 2015, and is likely to grow at 11.7% CAGR during the forecast period. Increasing geriatric population and growing prevalence of respiratory diseases will drive therapeutic respiratory devices market size. According to CDC, COPD prevalence increased from 3.2% among those aged 18-44 years to more than 11.6% among those exceeding 65 years.

https://www.gminsights.com/industry-analysis/therapeutic-respiratory-devices-market-report

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter